Political Reporter Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.

Press releases published on September 14, 2026

Sep. 14, 2026

Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)

Indeterminate GlobeNewswire

Sep. 14, 2026

PBS Aerospace Completes Roswell Expansion, Doubles Engine Test Capacity and Prepares Second Production Shift

Indeterminate GlobeNewswire

Sep. 14, 2026

Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines

Indeterminate GlobeNewswire

Sep. 14, 2026

Communiqué de presse : Sanofi et Cheplapharm créent un nouveau partenariat stratégique autour des médicaments matures

Indeterminate GlobeNewswire

Sep. 14, 2026

ArcelorMittal statement regarding missile strike on its Ukraine plant

Indeterminate GlobeNewswire

Sep. 14, 2026

Veteran-Owned New York Cannabis Brand Silly Nice Calls for Greater Visibility for Veterans in the Legal Cannabis Industry

Indeterminate GlobeNewswire

Sep. 14, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire

Sep. 14, 2026

Photonic Inc. unveils Project VANGUARD, a proposal for a $500M specialized semiconductor manufacturing facility to accelerate commercialization of quantum, AI and defence innovation in Canada

Indeterminate GlobeNewswire

Sep. 14, 2026

Department of War Makes Landmark $450 Million Committed Investment in The Elmet Group to Secure America’s Tungsten Supply Chain

Indeterminate GlobeNewswire

Sep. 14, 2026

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Indeterminate GlobeNewswire

Sep. 14, 2026

Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo

Indeterminate GlobeNewswire

Sep. 14, 2026

Ipsos : Kelly Beaver accélère l’exécution du plan stratégique Horizons

Indeterminate GlobeNewswire

Sep. 14, 2026

Ipsos: Kelly Beaver accelerates the execution of the Horizons strategic plan

Indeterminate GlobeNewswire

Sep. 14, 2026

NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

NANOBIOTIX annonce les résultats complets de la phase 1 pour JNJ-1900 (NBTXR3) dans le cancer du poumon non à petites cellules inopérable et récurrent

Indeterminate GlobeNewswire